SCEMBLIX

This brand name is authorized in Austria, Australia, Canada, Estonia, Spain, France, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Romania, United Kingdom, United States

Active ingredients

The drug SCEMBLIX contains one active pharmaceutical ingredient (API):

1 Asciminib UNII C5U34S9XFV - ASCIMINIB HYDROCHLORIDE

Asciminib is a potent inhibitor of ABL/BCR::ABL1 tyrosine kinase. Asciminib inhibits the ABL1 kinase activity of the BCR::ABL1 fusion protein by specifically targeting the ABL myristoyl pocket. Read about Asciminib

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SCEMBLIX Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01EA06		L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01E Protein kinase inhibitors → L01EA BCR-ABL tyrosine kinase inhibitors
Discover more medicines within L01EA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02528320, 02528339
Country: EE	Ravimiamet	Identifier(s): 1888724, 1888735, 1888746, 1888757, 3039948
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1221670002, 1221670004
Country: FR	Base de données publique des médicaments	Identifier(s): 65990614, 67826243
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 9247, 9248
Country: IT	Agenzia del Farmaco	Identifier(s): 050185014, 050185026, 050185038, 050185040, 050185053
Country: JP	医薬品医療機器総合機構	Identifier(s): 4291077F1027, 4291077F2023
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1095412, 1095413, 1095414, 1095415
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W69170001, W69170002, W69171001, W69171002
Country: US	FDA, National Drug Code	Identifier(s): 0078-1091, 0078-1098